Florence Chaverneff, PhD

Burden and progression of coronary atherosclerosis was found to be worsened in non-obese patients with rheumatoid arthritis and low vs high LDL levels.

On March 6, 2020, the American College of Cardiology issued COVID-19 clinical guidance for the cardiovascular care team.

Empagliflozin was not found to affect the exercise ability of patients with chronic heart failure with reduced or preserved ejection fraction after 12 weeks of treatment.

The Food and Drug Administration issued a safety warning on October 28, 2019, concerning the risks associated with the use of AFX endovascular grafts manufactured by Endologix, Inc. in patients with an abdominal aortic aneurysm.

The American Heart Association launched in December 2018 a 30 minute-long online course titled “Opioid Education for Healthcare Providers.”

April 28, 2018 is National Prescription Drug Take Back Day.

The majority of children diagnosed with definite arteriopathy and presenting with dissection and transient cerebral arteriopathy of childhood had headache complaints.